GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
    • Reports
      • GHTM
      • Scientific Advisory Board
      • FCT
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
Home / Sem categoria / Enhancing vector-borne disease research and control: the impact of VIASEF

Enhancing vector-borne disease research and control: the impact of VIASEF

September 5, 2024

VIASEF is a biocontainment infrastructure designed to facilitate research and development activities with invasive, exotic, or transgenic arthropods and human/animal pathogens transmitted by them that may pose biosecurity risks. Its a convertible infrastructure, able to address different types of public health emergencies. This was evidenced when, within the first six months of its inauguration, VIASEF focused its research on SARS-CoV-2, while establishing mosquito colonies of medical importance.

VIASEF has made significant contributions to vector-borne disease research and control.

Projects have focused on innovative vector control strategies, within the framework of insecticides, repellents, and trapping methods have shown enhanced efficacy in reducing vector populations and disease transmission. Moreover, VIASEF has contributed for the testing of innovative compounds as mosquito repellents/larvicides and is part of a project led by the University of California Malaria Initiative (UCMI) in São Tomé and Príncipe, involving field research on malaria mosquito vectors and capacity building on transgenic technologies, as a novel tool to eliminate malaria transmission in the region. Also, it is involved in developing an artificial diet (BLOODless) as an alternative to vertebrate blood which is traditionally used to feed mosquitoes, currently being tested in various African countries to assess its applicability and sustainability.

Achievements include innovations like a bloodless mosquito diet and a spatial repellent for malaria control.

VIASEF

Furthermore, VIASEF acts as a hub for teaching and collaborations with local communities and healthcare professionals, fostering knowledge transfer and capacity building. This has allowed individuals and institutions to effectively manage vector-borne diseases, leading to improved prevention and control. The UCMI in São Tomé and Príncipe, for example, facilitates the exchange of knowledge and expertise among partners. VIASEF also provides an exceptional environment for the development of MSc and PhD theses, with 3 MSc theses concluded and supporting 2 ongoing PhD theses thus far. Findings have informed public health policies at both regional and national levels.

VIASEF has improved disease surveillance, diagnostic tools, and knowledge transfer, improving public health and societal well-being.

The impact achieved is a proof of collaborative efforts, significant funding, partnerships with various stakeholders and dissemination through scientific publications and conferences. Overall, VIASEF, the only one of its kind in Portugal, has changed vector-borne disease research and control, leading to significant advancements in vector control strategies, disease surveillance, diagnostics, and policy influence.

Click here to visit VIASEF and get updates on the most recent projects.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

 

Loading Comments...
 

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok